Siamak Daneshmand, MD, Urology, Los Angeles, CA, Keck Hospital of USC

SiamakDaneshmandMD

Urology Los Angeles, CA

Surgical Oncology

Associate Professor of Urology (Clinical Scholar); Director of Urologic Oncology

Dr. Daneshmand is on Doximity

As a Doximity member you'll join over a million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Daneshmand's full profile

Already have an account?

Summary

  • BIOGRAPHY
    Dr. Sia Daneshmand earned his medical degree at the University of California, Davis and completed his residency at USC followed by a two-year fellowship in Urologic Oncology at the USC/Norris Comprehensive Cancer Center. He was recruited back to USC Institute of Urology in 2010 as Director of Urologic Oncology. He is currently an Associate Professor of Urology with Clinical Scholar designation and serves as director of clinical research as well as the urologic oncology (SUO) fellowship director.
    Dr. Daneshmand’s main interests include bladder cancer, testicular cancer, advanced kidney cancer and prostate cancer. He has extensive experience in urinary diversion and reconstruction following radical cystectomy as well as nerve-sparing retroperitoneal lymph node dissection (RPLND) following chemotherapy for advanced testis cancer. He is one of the highest volume surgeons for this disease on the west coast and has been selected as one of “True Experts” in the Testicular Cancer Resource Center web site. He also has extensive experience in the management of advanced kidney cancers with vena caval tumor thrombus involvement, retroperitoneal sarcomas and surgeries requiring requiring resection of the great vessels. His research interests include the use of pathways to improve peri-operative outcomes and he is a leading authority on enhanced recovery after surgery (ERAS) following radical cystectomy. He serves on the editorial board of the Journal of Urology, the scientific advisory board of Bladder Cancer Advocacy Network (BCAN) as well as the AUA/SUO Guideline Committee on non-muscle invasive bladder cancer. He is a member of Alpha Omega Alpha medical honor society, and has been designated one of the “America’s Top Cancer Doctors” for numerous consecutive years.
    He is an active member of the Society of Urologic Oncology, has presented over 300 abstracts at scientific meetings and has authored over 200 peer-reviewed articles, reviews, and chapters.

Education & Training

  • USC/Norris Comprehensive Cancer CenterFellowship, UROLOGIC ONCOLOGY, 2002 - 2004
  • University of Southern California - LAC+USC Medical Center
    University of Southern California - LAC+USC Medical CenterResidency, Urology, 1996 - 2002
  • University of California Davis School of Medicine
    University of California Davis School of MedicineClass of 1996
  • University of California, Los AngelesB.S., Microbiology & Molecular Genetics, Magna Cum Laude, 1988 - 1992

Certifications & Licensure

  • OR State Medical License
    OR State Medical License 2004 - Present
  • CA State Medical License
    CA State Medical License 1997 - 2023
  • American Board of Urology Urology

Awards, Honors, & Recognition

  • America's Top Doctors Castle Connolly, 2010-2017
  • America's Top Doctors for Cancer Castle Connolly, 2009-2017
  • Winner Best Poster of Session AUA, 2016
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Development and Validation of Consensus Contouring Guidelines for Adjuvant Radiation Therapy for Bladder Cancer After Radical Cystectomy  
    Baumann BC, Bosch WR, Bahl A, Birtle AJ, Breau RH, Challapalli A, Chang AJ, Choudhury A, Daneshmand S, El-Gayed A, Feldman A, Finkelstein SE, Guzzo TJ, Hilman S, Jani ..., Int J Radiat Oncol Biol Phys, 1/1/2016
  • Predictors of time to biochemical recurrence in a radical prostatectomy cohort within the PSA-era  
    Shahabi A, Satkunasivam R, Gill IS, Lieskovsky G, Daneshmand S, Pinski JK, Stern MC, Can Urol Assoc J, 1/1/2016
  • Collaborating to Move Research Forward: Proceedings of the 10th Annual Bladder Cancer Think Tank  
    Kamat AM, Agarwal P, Bivalacqua T, Chisolm S, Daneshmand S, Doroshow JH, Efstathiou JA, Galsky M, Iyer G, Kassouf W, Shah J, Taylor J, Williams SB, Quale DZ, Rosenberg JE, Bladder Cancer, 1/1/2016
  • Join now to see all

Books/Book Chapters

  • Join now to see all

Abstracts/Posters

  • Baseline GFR and cisplatin-induced renal toxicity in urothelial cancer patients.
    Adrienne Tran, Janice Loh, Lingyun Ji, Siamak Daneshmand, Anne K. Schuckman, Susan G. Groshen, David I. Quinn, Tanya B. Dorff, GU Cancer Syposium, San Francisco, CA, 1/1/2016
  • Development and validation of contouring guidelines for post-cystectomy adjuvant radiation of bladder cancer.
    Brian C. Baumann, Walter Bosch, Amit Bahl, Alison J. Birtle, Rodney H. Breau, Amarnath Challapalli, Albert Chang, Ananya Choudhury, Siamak Daneshmand, Adam S. Feldman,..., GU Cancer Syposium, San Francisco, CA, 1/1/2016
  • Impact of salvage surgery and radiotherapy on overall survival in patients with recurrent primary urethral cancer.
    Georgios Gakis, Todd Matthew Morgan, Siamak Daneshmand, Kirk A. Keegan, Johannes Mischinger, Tina Schubert, Rebecca Helen Clayman, Harras B Zaid, Jan Hrbacek, Bedeir A..., GU Cancer Syposium, San Francisco, CA, 1/1/2016
  • Join now to see all

Lectures

  • 4 day hospital stay following radical cystectomy. Is it feasible in Europe? 
    Lisbon, Portugal - 1/1/2016
  • Urinary Diversion, Bladder Cancer, Upper Tract Urothelial cancer 
    Mclean, VA - 1/1/2016
  • Evaluation of Gastrointestinal Complications Following Radical Cystectomy Using Enhanced Recovery Protocol 
    Washington, DC - 1/1/2016
  • Join now to see all

Other

  • Lymph node dissection in bladder cancer. (Performed radical cystectomy for bladder cancer.) 
    Daneshmand S, Labbafinejad Urology Department
    Shahid Beheshti University of Medical Sciences, Tehran, Iran - 1/1/2014
  • Health Heroes- Blue light cystoscopy 
    Daneshmand S, Discovery Health
    1/1/2013
  • Treatment for Testicular cancer. 
    Daneshmand S, Doctors TV show
    http://www.thedoctorstv.com/videolib/init/8028
    1/1/2012
  • Join now to see all

Authored Content

  • Is Imperative Partial Nephrectomy Feasible for Kidney Cancer with Venous Thrombus Involvement? Outcomes of 42 Cases and Matched Pair Analysis with a Large Radical Nephrectomy CohortMay 2018

Press Mentions

  • Delayed RC for Histologic Variant Urothelial Bladder Cancer Ups Death Risk
    Delayed RC for Histologic Variant Urothelial Bladder Cancer Ups Death RiskAugust 22nd, 2019
  • Taris Announces Positive Results of Phase 1b Trial of Tar-200 in Muscle Invasive Bladder Cancer
    Taris Announces Positive Results of Phase 1b Trial of Tar-200 in Muscle Invasive Bladder CancerJuly 12th, 2019
  • Blue Light Cystoscopy Improves Bladder Ca Detection
    Blue Light Cystoscopy Improves Bladder Ca DetectionOctober 6th, 2017
  • Join now to see all

Professional Memberships

Hospital Affiliations